Cronos Group (NASDAQ:CRON) Stock Rating Lowered by Wall Street Zen

Cronos Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Cronos Group (NASDAQ:CRON - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued on Saturday, Wall Street Zen reports.

A number of other equities analysts also recently commented on the stock. Weiss Ratings upgraded shares of Cronos Group from a "buy (b-)" rating to a "buy (b)" rating in a research note on Thursday, October 8th. TD Securities reaffirmed a "buy" rating on shares of Cronos Group in a research report on Monday, September 28th. Finally, Zacks Research upgraded Cronos Group from a "hold" rating to a "strong-buy" rating in a report on Thursday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $2.30.

Get Our Latest Report on Cronos Group

Cronos Group Stock Down 1.3%

Cronos Group stock opened at $3.04 on Friday. The stock has a market capitalization of $1.11 billion, a PE ratio of 40.88 and a beta of 0.96. Cronos Group has a twelve month low of $2.28 and a twelve month high of $3.91. The company has a 50 day moving average of $3.32 and a 200-day moving average of $2.91.

Cronos Group (NASDAQ:CRON - Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.01. Cronos Group had a return on equity of 2.56% and a net margin of 28.04%. The business had revenue of $63.45 million during the quarter, compared to the consensus estimate of $51.15 million. Equities analysts anticipate that Cronos Group will post 0.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Cronos Group

Hedge funds have recently bought and sold shares of the stock. Goldman Sachs Group Inc. grew its position in shares of Cronos Group by 23.5% in the third quarter. Goldman Sachs Group Inc. now owns 671,031 shares of the company's stock valued at $2,214,000 after purchasing an additional 127,795 shares during the last quarter. Jump Financial LLC acquired a new stake in Cronos Group during the 3rd quarter worth approximately $234,000. State Street Corp acquired a new stake in Cronos Group during the 3rd quarter worth approximately $404,000. Private Advisor Group LLC boosted its stake in Cronos Group by 10.0% in the 3rd quarter. Private Advisor Group LLC now owns 32,681 shares of the company's stock valued at $108,000 after purchasing an additional 2,984 shares during the period. Finally, HighTower Advisors LLC bought a new stake in Cronos Group in the 3rd quarter valued at $1,198,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.

Cronos Group Company Profile

(Get Free Report)

Cronos Group is a cannabinoid company that develops, produces, and markets cannabis and cannabis-derived products. Its business includes cultivation, processing, product development, and distribution. The company sells products in categories such as dried cannabis flower, pre-rolls, vaporizers, edibles, and extracts. Its brand portfolio includes Spinach and PEACE NATURALS. Founded in 2012 and headquartered in Toronto, Cronos serves consumers in Canada and select international markets, including Israel.

Featured Stories

Analyst Recommendations for Cronos Group (NASDAQ:CRON)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines